| Q50740072 | 3-Mercaptopropionic Acid-Induced Repetitive Seizures Increase GluN2A Expression in Rat Hippocampus: A Potential Neuroprotective Role of Cyclopentyladenosine |
| Q48605475 | A novel anti-epileptic agent, perampanel, selectively inhibits AMPA receptor-mediated synaptic transmission in the hippocampus |
| Q43007338 | Activation of adenosine A2A receptors induces TrkB translocation and increases BDNF-mediated phospho-TrkB localization in lipid rafts: implications for neuromodulation |
| Q47557465 | Acute ethanol exposure has bidirectional actions on the endogenous neuromodulator adenosine in rat hippocampus. |
| Q51007657 | Acute restraint stress in zebrafish: behavioral parameters and purinergic signaling |
| Q30361871 | Adenosine A(2A) receptor up-regulates retinal wave frequency via starburst amacrine cells in the developing rat retina |
| Q48433380 | Adenosine A1 Receptor Suppresses Tonic GABAA Receptor Currents in Hippocampal Pyramidal Cells and in a Defined Subpopulation of Interneurons |
| Q47095276 | Adenosine A1-A2A Receptor Heteromer as a Possible Target for Early-Onset Parkinson's Disease |
| Q57778947 | Adenosine A2A Receptors: Localization and Function |
| Q47658900 | Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine-induced blood brain barrier dysfunction via suppression of MLCK signaling pathway |
| Q41849265 | Adenosine A2A receptor binding profile of two antagonists, ST1535 and KW6002: consideration on the presence of atypical adenosine A2A binding sites |
| Q34004979 | Adenosine A2A receptors activation facilitates neuromuscular transmission in the pre-symptomatic phase of the SOD1(G93A) ALS mice, but not in the symptomatic phase. |
| Q41768581 | Adenosine A2A receptors in neuronal outgrowth: a target for nerve regeneration? |
| Q37150330 | Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study. |
| Q37963718 | Adenosine A2A-receptor antagonism and pathophysiology of Parkinson's disease and drug-induced movement disorders |
| Q47674396 | Adenosine A2b receptors control A1 receptor-mediated inhibition of synaptic transmission in the mouse hippocampus |
| Q47570950 | Adenosine A3 receptor agonists: do recent findings offer new hope in chronic pain treatment? |
| Q60305250 | Adenosine Actions on Oligodendroglia and Myelination in Autism Spectrum Disorder |
| Q30355611 | Adenosine Kinase Deficiency in the Brain Results in Maladaptive Synaptic Plasticity. |
| Q26852056 | Adenosine Kinase: Exploitation for Therapeutic Gain |
| Q48585087 | Adenosine Type A2A Receptor in Peripheral Cell from Patients with Alzheimer's Disease, Vascular Dementia, and Idiopathic Normal Pressure Hydrocephalus: A New/Old Potential Target |
| Q30466024 | Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia. |
| Q36036212 | Adenosine dysfunction in epilepsy |
| Q34216355 | Adenosine receptor signaling modulates permeability of the blood-brain barrier. |
| Q26795435 | Adenosine receptor signaling: a key to opening the blood-brain door |
| Q47818971 | Adenosine receptors as markers of brain iron deficiency: Implications for Restless Legs Syndrome |
| Q34211096 | Adenosine transport by plasma membrane monoamine transporter: reinvestigation and comparison with organic cations |
| Q38075271 | Adenosine: setting the stage for plasticity |
| Q55003224 | Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors. |
| Q48116052 | Anoxic depolarization of hippocampal astrocytes: Possible modulation by P2X7 receptors |
| Q91863400 | Antidepressant-Like Activity of Typical Antidepressant Drugs in the Forced Swim Test and Tail Suspension Test in Mice Is Augmented by DMPX, an Adenosine A2A Receptor Antagonist |
| Q48132428 | Axonal elongation and dendritic branching is enhanced by adenosine A2A receptors activation in cerebral cortical neurons |
| Q42100797 | Basal adenosine modulates the functional properties of AMPA receptors in mouse hippocampal neurons through the activation of A1R A2AR and A3R. |
| Q84265038 | Beneficial effects of theophylline infusions in surgical patients with intra-abdominal hypertension |
| Q35091761 | Boron-doped diamond nano/microelectrodes for biosensing and in vitro measurements |
| Q53139562 | Caffeine Mitigates the Locomotor Hyperactivity in Middle-aged Low-density Lipoprotein Receptor (LDLr)-Knockout Mice |
| Q28080581 | Caffeine: cognitive and physical performance enhancer or psychoactive drug? |
| Q41232330 | Cobra neurotoxin produces central analgesic and hyperalgesic actions via adenosine A1 and A2A receptors |
| Q34968064 | Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor |
| Q42882109 | Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors |
| Q48880610 | Desensitization of adenosine A1 receptors in rat immature cortical neurons |
| Q36674667 | Dysregulation of brain adenosine is detrimental to the expression of conditioned freezing but not general Pavlovian learning |
| Q44778310 | Effective Attenuation of Adenosine A1R Signaling by Neurabin Requires Oligomerization of Neurabin |
| Q90385461 | Effects of Preinjury and Postinjury Exposure to Caffeine in a Rat Model of Traumatic Brain Injury |
| Q36471040 | Effects of the adenosinergic system on the expression and acquisition of sensitization to conditioned place preference in morphine-conditioned rats |
| Q37385936 | Ethanol and Caffeine Effects on Social Interaction and Recognition in Mice: Involvement of Adenosine A2A and A1 Receptors |
| Q36699593 | Extracellular guanosine regulates extracellular adenosine levels |
| Q36912637 | Glial adenosine kinase--a neuropathological marker of the epileptic brain |
| Q33902942 | Guanosine regulates adenosine levels in the kidney |
| Q38990106 | Hippocampal GABAergic transmission: a new target for adenosine control of excitability |
| Q50125651 | Impact of Coffee and Cacao Purine Metabolites on Neuroplasticity and Neurodegenerative Disease |
| Q40732525 | Inhibition of PDE2A, but not PDE9A, modulates presynaptic short-term plasticity measured by paired-pulse facilitation in the CA1 region of the hippocampus |
| Q35662011 | Intrathecal injection of adenosine 2A receptor agonists reversed neuropathic allodynia through protein kinase (PK)A/PKC signaling. |
| Q50023885 | Layer- and Cell Type-Specific Modulation of Excitatory Neuronal Activity in the Neocortex |
| Q36171090 | Lighting up G protein-coupled purinergic receptors with engineered fluorescent ligands. |
| Q48445940 | Mdivi-1 Protects Against Ischemic Brain Injury via Elevating Extracellular Adenosine in a cAMP/CREB-CD39-Dependent Manner |
| Q57966662 | Measuring brain activity with magnetoresistive sensors integrated in micromachined probe needles |
| Q38606240 | Modulation of Central Synapses by Astrocyte-Released ATP and Postsynaptic P2X Receptors. |
| Q38358456 | Modulation of excitatory neurotransmission by neuronal/glial signalling molecules: interplay between purinergic and glutamatergic systems |
| Q48413487 | Multiple pathways for elevating extracellular adenosine in the rat hippocampal CA1 region characterized by adenosine sensor cells |
| Q41775962 | Neurabin scaffolding of adenosine receptor and RGS4 regulates anti-seizure effect of endogenous adenosine. |
| Q36362895 | Neurabin: a key factor in the specific neuroprotection mediated by Adenosine |
| Q28541087 | Neurochemical measurement of adenosine in discrete brain regions of five strains of inbred mice |
| Q38110513 | Neuromodulation: Purinergic Signaling in Respiratory Control |
| Q47933159 | Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter. |
| Q36343219 | Optimization of adenosine 5'-carboxamide derivatives as adenosine receptor agonists using structure-based ligand design and fragment screening |
| Q40649047 | Overexpression of Adenosine A2A Receptors in Rats: Effects on Depression, Locomotion, and Anxiety |
| Q34744881 | PQ-69, a novel and selective adenosine A1 receptor antagonist with inverse agonist activity |
| Q39157893 | Pathological overproduction: the bad side of adenosine. |
| Q33616120 | Peripheral blood mononuclear cells as a laboratory to study dementia in the elderly |
| Q52573336 | Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents. |
| Q42751053 | Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial |
| Q36289476 | Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission |
| Q91754514 | Purinergic Signalling in Parkinson's Disease: A Multi-target System to Combat Neurodegeneration |
| Q37826775 | Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis |
| Q43157485 | Reconstruction of the adenosine system by bone marrow-derived mesenchymal stem cell transplantation |
| Q35916855 | Reduced neurobehavioral impairment from sleep deprivation in older adults: contribution of adenosinergic mechanisms |
| Q42700576 | Reducing Extracellular Ca2+ Induces Adenosine Release via Equilibrative Nucleoside Transporters to Provide Negative Feedback Control of Activity in the Hippocampus |
| Q40121091 | Regulation of TrkB receptor translocation to lipid rafts by adenosine A(2A) receptors and its functional implications for BDNF-induced regulation of synaptic plasticity |
| Q41924569 | Regulation of cell proliferation by the guanosine-adenosine mechanism: role of adenosine receptors |
| Q48733431 | Repetitive systemic morphine alters activity-dependent plasticity of Schaffer-collateral-CA1 pyramidal cell synapses: involvement of adenosine A1 receptors and adenosine deaminase. |
| Q48112379 | Role of adenosine A2A receptors in motor control: relevance to Parkinson's disease and dyskinesia |
| Q34306247 | Structure based prediction of subtype-selectivity for adenosine receptor antagonists |
| Q36546173 | Structure-activity relationships and molecular modeling of 1,2,4-triazoles as adenosine receptor antagonists |
| Q33560239 | Structure-based discovery of A2A adenosine receptor ligands |
| Q30435017 | Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists |
| Q26748944 | The Adenosinergic System in Diabetic Retinopathy |
| Q30973484 | The Chemistry of Neurodegeneration: Kinetic Data and Their Implications |
| Q44253645 | The Imbalanced Expression of Adenosine Receptors in an Epilepsy Model Corrected Using Targeted Mesenchymal Stem Cell Transplantation |
| Q93186026 | The Purinome and the preBötzinger Complex - A Ménage of Unexplored Mechanisms That May Modulate/Shape the Hypoxic Ventilatory Response |
| Q92920850 | The Role of Altered BDNF/TrkB Signaling in Amyotrophic Lateral Sclerosis |
| Q37852727 | The Role of Extracellular Adenosine in Chemical Neurotransmission in the Hippocampus and Basal Ganglia: Pharmacological and Clinical Aspects |
| Q46594720 | The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT. |
| Q37876534 | The structure of the adenosine receptors: implications for drug discovery. |
| Q53096946 | Treatment with Adenosine Receptor Agonist Ameliorates Pain Induced by Acute and Chronic Inflammation |
| Q37700201 | Tuning and fine-tuning of synapses with adenosine. |
| Q33971113 | Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review. |
| Q89036777 | Withdrawal of caffeine after its chronic administration modifies the antidepressant-like activity of atypical antidepressants in mice. Changes in cortical expression of Comt, Slc6a15 and Adora1 genes |
| Q36007799 | Working memory and the homeostatic control of brain adenosine by adenosine kinase |